Development and validation of a robust RP-HPLC method for Landiolol using analytical quality by design

Read full text Summarise with VIRAT
Authors: S. Harshini, Panneerselvam Theivendren, Saravanan Govindaraj
Cited by: 0
References: 38

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

A systematic Analytical Quality by Design based reverse-phase high-performance liquid chromatography method was successfully developed and validated for the quantification of Landiolol in pharmaceutical formulations. The method optimization employed Central Composite Design with Analysis of Variance revealing a statistically significant model (F-value = 11.60, p = 0.0003). The optimized chromatographic conditions included an Inertsil ODS column (150 × 4.6 mm, 5 μm), mobile phase comprising 55% sodium dihydrogen phosphate and 0.2% orthophosphoric acid, flow rate of 1.25 mL/min, injection volume of 15 µL, and detection wavelength of 240 nm, yielding a retention time of 2.70 min. The validated method demonstrated excellent system suitability with USP tailing factor of 1.0, plate count of 10,925, and similarity factor of 98.4%. System precision showed exceptional reproducibility with %RSD of 0.3%, while linearity was established over the concentration range with R² = 0.9999. Accuracy studies revealed recoveries between 100.8 and 101.1% across 50%, 100%, and 150% levels. Forced degradation studies indicated Landiolol stability under thermal (3% degradation) and oxidative conditions (4% degradation) but significant photolytic degradation (9%). The greenness assessment yielded a score of 0.88, confirming environmental sustainability. This robust, precise, and environmentally conscious analytical method complies with regulatory guidelines for routine quality control and pharmaceutical analysis of Landiolol formulations.

Fields of Study & Subjects

Analytical Methods in Pharmaceuticals Analytical Chemistry and Chromatography Biosimilars and Bioanalytical Methods

Publication details

Journal / source
Discover Chemistry.
Volume
3
Issue
1
Pages
173
Publication date
31 March 2026
Language
EN